Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
---|
09/12/2003 | WO2003073997A2 Treatment of septic shock |
09/12/2003 | WO2002028424A9 Kyberdrug as autovaccines with immune-regulating effects |
09/12/2003 | CA2841310A1 Electrolyte purgative |
09/12/2003 | CA2478145A1 Formulations and methods of using nitric oxide mimetics in cancer treatment |
09/12/2003 | CA2478135A1 Electrolyte purgative |
09/11/2003 | US20030171340 Treating antibiotic-resistant infections with a metal complex of tetracycline, glycylcycline, or quinolone antibiotics, or administering a metal compound and the antibiotic together for in situ formation of the complex |
09/11/2003 | US20030170893 Nanocapsule encapsulation system and method |
09/11/2003 | US20030170327 Vitamin and zinc monomethionine compositions |
09/11/2003 | US20030170319 Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
09/11/2003 | US20030170318 Treating cancer by administering a fluoride or a salt thereof; e.g., sodium fluoride, calcium fluoride, magnesium fluoride, potassium fluoride, aluminum fluoride, strontium fluoride or sodium monofluorophosphate. |
09/11/2003 | US20030170315 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter |
09/11/2003 | US20030170314 Carrier; and an atomically disordered, nanocrystalline metal-containing (especially silver) compound; may be antimicrobial, antinflammatory, anticancer, proapoptosis and/or an MMP modulating |
09/11/2003 | US20030170300 Combination chemotherapy |
09/11/2003 | US20030170280 Particles comprising porous and/ or polycrystalline silicon or multilayer porous silicon oxide mirrors; sunscreen agents |
09/11/2003 | US20030170223 Pulmonary vasodilator surfactant compositions and method of use |
09/11/2003 | US20030170201 Polymeric micelle containing cisplatin enclosed therein and use thereof |
09/11/2003 | US20030170185 To enhance the remineralization |
09/11/2003 | US20030167924 Portable oxygen concentrator |
09/10/2003 | EP1341546A2 Kyberdrug as autovaccines with immune-regulating effects |
09/10/2003 | EP1341520A2 Antibiotic/benzoyl peroxide dispenser |
09/10/2003 | EP1341500A1 Antifungal nail composition and method of use |
09/10/2003 | EP1248601B1 Control of microbial populations in the gastrointestinal tract of animals |
09/10/2003 | EP0737067B1 Treatment of hormone-unresponsive metastatic prostate cancer |
09/10/2003 | CN1441841A Stimulation of cellular regeneration and differentiation in inner ear |
09/10/2003 | CN1440796A Medicine for clearing away heat and toxic matter, promoting diuresis and stopping itching |
09/10/2003 | CN1440773A Prepn process of Qingkailing injection and injection powder and its quality control method |
09/10/2003 | CN1120721C External applied ointment for treating piles |
09/10/2003 | CN1120716C Plaster for curing bony spur and its preparing process |
09/09/2003 | US6616941 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
09/09/2003 | US6616938 Method of making chewing gum containing colloidal bismuth subcitrate |
09/09/2003 | CA2227740C Gastrointestinal drug composition |
09/04/2003 | WO2003072196A1 Lower esophagus tissue modifier |
09/04/2003 | WO2003072116A1 Use of zeolithes for reducing the proportion of lactates and ammonium in human and animal organisms |
09/04/2003 | WO2003072111A2 Omega-3 fatty acids or omega-3 phosphatidylcholine in the treatment of depression |
09/04/2003 | WO2003072048A2 Symptomatic relief of gastrointestinal disorders |
09/04/2003 | WO2003072024A2 Methods of treating vascular disease |
09/04/2003 | WO2003072023A2 Novel compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer |
09/04/2003 | WO2003063840A3 Transmucosal delivery of proton pump inhibitors |
09/04/2003 | WO2003050053A3 Use of an antimicrobial glass ceramic for dental care and oral hygiene |
09/04/2003 | WO2000067776A9 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
09/04/2003 | US20030166617 Combination therapies with vascular damaging activity |
09/04/2003 | US20030166607 A trehalose solution comprising one or more metal ions, and neutral PH |
09/04/2003 | US20030165582 Plant extracts; aging resistance; skin disorders |
09/04/2003 | US20030165578 Regulation of wound healing by nitric oxide |
09/04/2003 | US20030165576 Antitumor effect potentiators |
09/04/2003 | US20030165575 Methods and compositions for treatment and diagnosis of alzheimer disease and other disorders |
09/04/2003 | US20030165440 Mixture of water insoluble calcium compound and polyelectrolytes |
09/04/2003 | US20030164339 Process for producing sterile water for injection from potable water |
09/04/2003 | CA2475963A1 Methods of treating vascular disease |
09/03/2003 | EP1339429A2 Composition containing statins and calcium for improved cardiovascular health |
09/03/2003 | EP1339428A1 Inhalation of nitric oxide |
09/03/2003 | EP1339417A1 Preparation for the treatment of surface open wounds |
09/03/2003 | EP1339416A1 Trace elements |
09/03/2003 | EP1339415A1 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator |
09/03/2003 | EP1339414A2 L-histidine in ophthalmic solutions |
09/03/2003 | EP1339294A1 Nutritional composition for an immune condition |
09/03/2003 | EP1339282A1 Hydrophilic polymer blends used for dry cow therapy |
09/03/2003 | EP1158992B1 Use of xenon for preparing a pharmaceutical preparation for treating neurointoxications |
09/03/2003 | EP0744171B1 Dental composition for hypersensitive dentin |
09/03/2003 | CN1440270A High cleaning dentifrice |
09/03/2003 | CN1440268A Promoting whole body health |
09/03/2003 | CN1440240A Preparation for prevention and/or treatment of vascular disorders |
09/03/2003 | CN1439429A Composite nutritive complementary tablets (particles) |
09/03/2003 | CN1439406A Medicament for burn and scald |
09/03/2003 | CN1120016C Medicine ointment for skin allergy caused by violet ray and cosmetics, dermatitis and other skin diseases |
09/03/2003 | CN1120014C Chinese patent medicine for treating hyperosteogeny |
09/03/2003 | CN1120008C Method for preparing Chinese medicine for curing epilepsy |
09/03/2003 | CN1120004C Coated gongyanping tablet in special shape and its making process |
09/03/2003 | CN1120002C Application of ammonium nilrate in pharmaceutical industry, food and health-care product |
09/02/2003 | US6613753 Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation |
09/02/2003 | US6613367 Complete nutrition of infants products are characterized by the type and amount of protein and carbohydrate and the increased levels of folic acid, vitamin B6 and vitamin B12 or their functional equivalents. These products improve feelings |
08/28/2003 | WO2003070961A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them |
08/28/2003 | WO2003070919A1 Antimicrobial composition |
08/28/2003 | WO2003070733A1 Novel boronate esters |
08/28/2003 | WO2003070269A1 Treatment for diseases of the eye, inner ear and central nervous system |
08/28/2003 | WO2003070185A2 Method for treating cellulite |
08/28/2003 | WO2003070167A2 Therapeutic and prophylactic treatment of aging and disorders of aging in humans |
08/28/2003 | WO2003045274A3 Thermopolymer composition and related methods |
08/28/2003 | WO2003037297A3 Photosensitizer functionalised nanoparticles |
08/28/2003 | WO2002096219A3 Acid controlled viscosity fiber system and uses thereof |
08/28/2003 | WO2002078717A3 Compositions and methods for reducing rna virus pathogenicity |
08/28/2003 | WO2002028430A3 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid |
08/28/2003 | WO2001082949A3 Method of reducing side effects of chemotherapy in cancer patients |
08/28/2003 | US20030162829 Combination of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitor |
08/28/2003 | US20030162760 Dermal agent |
08/28/2003 | US20030161895 Comprising water, Xanthan gum, Magnesium aluminum silicate, Kaolin, Silicon dioxide, Sodium sulfacetamide, Sodium thiosulfate, Glyceryl stearate, PEG-100 Stearate, Quillaia saponaria extract, Benzyl alcohol, sulfur, high sorption base |
08/28/2003 | US20030161894 Prepared by reacting aqueous calcium hydroxide slurry with carbon dioxide in presence of acid such as nonanoic acid and selecting process parameters such that resulting aragonite calcium carbonate has specific gravity of less than 2.5 g/cm3 |
08/28/2003 | US20030161892 Cumin in powder or oil form is blood clotter in combination with unctuous host substance including petroleum jelly, coconut butter and antiseptics |
08/28/2003 | US20030161863 Administering mixtures of nutrients for prophylaxis of muscular, metabolic or respiratory disorders, injuries, inflammation and/or to relieve stress |
08/28/2003 | US20030161858 Mixtures of cement powders, vitamins, hormones, antibiotics, antitumor agents, somatotropins, calcium phosphates or proteins dissolved, dispersed or emulsified in oils; bone disorders |
08/28/2003 | US20030161811 Method for treating cervical cancer |
08/28/2003 | US20030159953 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof |
08/28/2003 | CA2476362A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them |
08/28/2003 | CA2475310A1 Antimicrobial streptococcus salivarius strain and use thereof for preventing dental caries |
08/27/2003 | EP1338307A1 Chemical and biological decontamination material and system |
08/27/2003 | EP1338284A1 Composition comprising sodium, potassium, calcium and magnesium |
08/27/2003 | EP1338281A1 Method for producing an immunotropic antiviral preparation |
08/27/2003 | EP1338280A1 Combination of amines and vanadium (iv)/(v) compounds for the treatment and/or prevention of diabetes mellitus |
08/27/2003 | EP1337283A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
08/27/2003 | EP1337275A1 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors |